STAT+: Here’s how Trump might approach his drug pricing plan
President Trump is expected to advance a "most-favored nation" policy to lower drug prices. How effective might it be? The devil will be in the details.
WASHINGTON — President Trump is widely expected to try to advance a “most-favored nation” policy next week in an effort to reduce U.S. drug prices — a move that is likely to significantly rattle the pharmaceutical industry, cheer his political base, and, possibly, leave open some very big questions.
The idea behind the policy, generally speaking, is simple: It would tie payments for drugs in the United States to prices paid by other developed countries, many of which pay far less than Americans for their medications. It’s also not a new idea: The first Trump administration tried to set it in motion, only for its plans to be blocked.
But now, having learned the lessons from that defeat, and with a majority in the House and the Senate, the administration could face better odds.
